Literature DB >> 15459509

Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III).

Valory N Pavlik1, David J Hyman, Rachelle Doody.   

Abstract

In the Third National Health and Nutrition Examination Survey (NHANES III), three measures of cognitive function [Simple Reaction Time Test (SRTT), Symbol Digit Substitution Test (SDST), and Serial Digit Learning Test (SDLT)] were administered to a half-sample of 3,385 adult men and nonpregnant women 30-59 years of age with no history of stroke. We used multiple linear regression analysis to determine whether there was an independent association between performance on each cognitive function measure and defined hypertension (HTN) alone, type 2 diabetes mellitus (DM) alone, and coexistent HTN and DM after adjustment for demographic and socioeconomic variables and selected health behaviors. After adjustment for the sociodemographic variables, the combination of HTN + DM, but not HTN alone or DM alone, was significantly associated with worse performance on the SRTT (p = 0.031) and the SDST (p = 0.011). A similar pattern was observed for SDLT performance, but the relationship did not reach statistical significance (p = 0.101). We conclude that HTN in combination with DM is associated with detectable cognitive decrements in persons under age 60.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459509     DOI: 10.1159/000081049

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  26 in total

1.  Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults.

Authors:  Ling Zheng; Wendy J Mack; Helena C Chui; Lara Heflin; Dan Mungas; Bruce Reed; Charles DeCarli; Michael W Weiner; Joel H Kramer
Journal:  J Am Geriatr Soc       Date:  2012-01-27       Impact factor: 5.562

2.  Physical activity, cognitive function, and mortality in a US national cohort.

Authors:  R F Gillum; Thomas O Obisesan
Journal:  Ann Epidemiol       Date:  2010-02-19       Impact factor: 3.797

Review 3.  The relationship between blood pressure and cognitive function.

Authors:  Vera Novak; Ihab Hajjar
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

4.  Cognitive functions and white matter lesions on magnetic resonance images in a sample of normal Iranian population with cardiovascular risk factors.

Authors:  Farzad Ashrafi; Morteza Sanei Taheri; Aida Farzaneh; Behdad Behnam; Mehran Arab Ahmadi
Journal:  Neuroradiol J       Date:  2019-01-24

Review 5.  Prehypertension: Underlying pathology and therapeutic options.

Authors:  Sulayma Albarwani; Sultan Al-Siyabi; Musbah O Tanira
Journal:  World J Cardiol       Date:  2014-08-26

6.  Incident cognitive impairment is elevated in the stroke belt: the REGARDS study.

Authors:  Virginia G Wadley; Frederick W Unverzagt; Lisa C McGuire; Claudia S Moy; Rodney Go; Brett Kissela; Leslie A McClure; Michael Crowe; Virginia J Howard; George Howard
Journal:  Ann Neurol       Date:  2011-05-26       Impact factor: 10.422

Review 7.  Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review.

Authors:  Keenan A Walker; Melinda C Power; Rebecca F Gottesman
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

8.  Aging, vascular risk, and cognition: blood glucose, pulse pressure, and cognitive performance in healthy adults.

Authors:  Cheryl L Dahle; Bradley S Jacobs; Naftali Raz
Journal:  Psychol Aging       Date:  2009-03

9.  Cognitive function, social integration and mortality in a U.S. national cohort study of older adults.

Authors:  Thomas O Obisesan; R F Gillum
Journal:  BMC Geriatr       Date:  2009-07-28       Impact factor: 3.921

10.  Genetic and environmental mediation of the associations between self-rated health and cognitive abilities.

Authors:  Pia Svedberg; Margaret Gatz; Nancy L Pedersen
Journal:  Exp Aging Res       Date:  2009 Apr-Jun       Impact factor: 1.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.